-The Times of India MUMBAI: A Mumbai hospital has put up a notice advising its doctors to avoid prescribing drugs manufactured by Ranbaxy Laboratories. This comes a fortnight after Ranbaxy Laboratories agreed to pay a $500-million penalty to US authorities for "selling adulterated drugs" in the American market. It is not known whether the two are linked. Consultants at Jaslok Hospital said an advisory was put up at the receptionist's circular desk...

-The United Nations A United Nations report released today stresses the importance of providing meals for schoolchildren, particularly in times of crisis, and notes that this is still lacking in many developing countries. "School feeding assures that where quality education is available, children are able to take advantage of the opportunity to learn," said the Executive Director of the World Food Programme (WFP), Ertharin Cousin. "It's an investment that pays off in the...

-The Telegraph Hyderabad: As rights groups accused the anti-Maoist militia Salwa Judum of atrocities on Chhattisgarh's villagers, its founder Mahendra Karma kept insisting his only aim was to "liberate" the tribals from the rebels' tyranny and propaganda. The future of the government-backed vigilante group, which still survives unofficially despite a Supreme Court order to disband it, now looks bleak after the Maoists killed Congress tribal leader Karma yesterday. The Salwa Judum (whose name...

-The Hindu   Ranbaxy's fraudulent practices may have jeopardised millions of lives in India, Africa and the U.S. Exactly two weeks ago, the pharmaceuticals industry was rocked by revelations that one of the world's largest generic drug manufacturers, Ranbaxy Laboratories, pleaded guilty to seven federal criminal charges stemming from its fraudulent production practices dating back to 2008, and agreed to pay U.S. regulators $500 million in fines. Much has since been said about Ranbaxy's...

-The Economic Times Indian pharmaceutical company Ranbaxy recently paid $500 million to the US government to settle civil and criminal charges for making fraudulent statements to the US FDA and selling adulterated drugs in the US. Dinesh Thakur, an ex-Ranbaxy employee who blew the whistle on the company, talks to ET about the five-year long investigation and the future of generic drug companies in the US. Edited Excerpts: * You think you...